Reckitt Benckiser Group (LON:RB)‘s stock had its “overweight” rating reiterated by equities research analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Wednesday. They currently have a GBX 7,500 ($101.71) price target on the stock. JPMorgan Chase & Co.’s price objective points to a potential upside of 9.52% from the stock’s current price.

RB has been the subject of several other research reports. Barclays restated an “equal weight” rating and issued a GBX 6,600 ($89.50) price target (down previously from GBX 7,100 ($96.28)) on shares of Reckitt Benckiser Group in a research note on Monday, November 27th. Royal Bank of Canada set a GBX 5,600 ($75.94) price target on shares of Reckitt Benckiser Group and gave the stock a “sell” rating in a research note on Friday, October 20th. Liberum Capital dropped their price target on shares of Reckitt Benckiser Group from GBX 8,700 ($117.98) to GBX 8,000 ($108.49) and set a “buy” rating for the company in a research note on Wednesday, October 25th. Kepler Capital Markets dropped their price target on shares of Reckitt Benckiser Group from GBX 7,800 ($105.78) to GBX 7,300 ($99.00) and set a “hold” rating for the company in a research note on Monday, October 9th. Finally, Deutsche Bank restated a “buy” rating and issued a GBX 8,500 ($115.27) price target on shares of Reckitt Benckiser Group in a research note on Thursday, October 12th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of GBX 7,664.55 ($103.94).

Reckitt Benckiser Group (LON RB) opened at GBX 6,848 ($92.87) on Wednesday. The company has a market cap of $48,190.00 and a price-to-earnings ratio of 2,290.30. Reckitt Benckiser Group has a 12 month low of GBX 6,299 ($85.42) and a 12 month high of GBX 8,110.43 ($109.99).

In other Reckitt Benckiser Group news, insider Adrian Nevil Hennah bought 2,285 shares of Reckitt Benckiser Group stock in a transaction dated Wednesday, November 8th. The stock was acquired at an average cost of GBX 6,567 ($89.06) per share, with a total value of £150,055.95 ($203,493.29). Also, insider Christopher Sinclair bought 2,800 shares of Reckitt Benckiser Group stock in a transaction dated Wednesday, November 1st. The stock was acquired at an average cost of GBX 6,597 ($89.46) per share, with a total value of £184,716 ($250,496.34).

TRADEMARK VIOLATION NOTICE: “JPMorgan Chase & Co. Reaffirms “Overweight” Rating for Reckitt Benckiser Group (RB)” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.watchlistnews.com/jpmorgan-chase-co-reaffirms-overweight-rating-for-reckitt-benckiser-group-rb/1800645.html.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.